Walker-Samuel S, Parker C C, Leach M O, Collins D J
Cancer Research UK Clinical Magnetic Resonance Imaging Research Group, Institute of Cancer Research, Royal Marsden NHS Foundation Trust, Sutton, Surrey SM2 5PT, UK.
Phys Med Biol. 2007 Jan 7;52(1):75-89. doi: 10.1088/0031-9155/52/1/006. Epub 2006 Dec 6.
Reference tissues are currently used to analyse dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) data. The assessment of tumour response to treatment with anti-cancer drugs is a particularly important application of this type of analysis and requires a measure of reproducibility to define a level above which a significant change due to therapy can be inferred. This study compares the reproducibility of such quantification strategies with that found using a published, group-averaged uptake curve. It is shown that reference tissue quantification gives poorer reproducibility for most parameters than that found using a group-averaged plasma curve (a change in K(trans) of greater than 41.8% and 16.4% would be considered significant in the two approaches, respectively), but successfully incorporates some of the variability observed in plasma kinetics between visits and provides vascular input functions that, across the group, are comparable with the group-averaged curve. This study therefore provides an indirect validation of the methodology.
目前,参考组织被用于分析动态对比增强磁共振成像(DCE-MRI)数据。评估肿瘤对抗癌药物治疗的反应是这类分析的一个特别重要的应用,并且需要一种可重复性的度量来定义一个水平,高于该水平就可以推断出由于治疗引起的显著变化。本研究将这种定量策略的可重复性与使用已发表的组平均摄取曲线所发现的可重复性进行了比较。结果表明,对于大多数参数而言,参考组织定量的可重复性比使用组平均血浆曲线时要差(在两种方法中,Ktrans的变化分别大于41.8%和16.4%时将被认为是显著的),但成功地纳入了不同就诊之间血浆动力学中观察到的一些变异性,并提供了全组范围内与组平均曲线相当的血管输入函数。因此,本研究为该方法提供了间接验证。